These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8226823)
1. Inhibition of vascular endothelial cell growth by activin-A. McCarthy SA; Bicknell R J Biol Chem; 1993 Nov; 268(31):23066-71. PubMed ID: 8226823 [TBL] [Abstract][Full Text] [Related]
2. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624 [TBL] [Abstract][Full Text] [Related]
3. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. Xu J; McKeehan K; Matsuzaki K; McKeehan WL J Biol Chem; 1995 Mar; 270(11):6308-13. PubMed ID: 7890768 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3. Takumi T; Moustakas A; Lin HY; Lodish HF Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622 [TBL] [Abstract][Full Text] [Related]
5. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Attisano L; Cárcamo J; Ventura F; Weis FM; Massagué J; Wrana JL Cell; 1993 Nov; 75(4):671-80. PubMed ID: 8242742 [TBL] [Abstract][Full Text] [Related]
6. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells. Erämaa M; Hildén K; Tuuri T; Ritvos O Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658 [TBL] [Abstract][Full Text] [Related]
7. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Lebrun JJ; Vale WW Mol Cell Biol; 1997 Mar; 17(3):1682-91. PubMed ID: 9032295 [TBL] [Abstract][Full Text] [Related]
8. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE). Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176 [TBL] [Abstract][Full Text] [Related]
10. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. Ebner R; Chen RH; Lawler S; Zioncheck T; Derynck R Science; 1993 Nov; 262(5135):900-2. PubMed ID: 8235612 [TBL] [Abstract][Full Text] [Related]
11. Characterization of type I receptors for transforming growth factor-beta and activin. ten Dijke P; Yamashita H; Ichijo H; Franzén P; Laiho M; Miyazono K; Heldin CH Science; 1994 Apr; 264(5155):101-4. PubMed ID: 8140412 [TBL] [Abstract][Full Text] [Related]
12. The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm. Bhushan A; Lin HY; Lodish HF; Kintner CR Mol Cell Biol; 1994 Jun; 14(6):4280-5. PubMed ID: 8196664 [TBL] [Abstract][Full Text] [Related]
13. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor. Matsuzaki K; Xu J; Wang F; McKeehan WL; Krummen L; Kan M J Biol Chem; 1993 Jun; 268(17):12719-23. PubMed ID: 8389764 [TBL] [Abstract][Full Text] [Related]
14. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas. Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304 [TBL] [Abstract][Full Text] [Related]
15. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer. Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055 [TBL] [Abstract][Full Text] [Related]
16. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A. Moustakas A; Takumi T; Lin HY; Lodish HF J Biol Chem; 1995 Jan; 270(2):765-9. PubMed ID: 7822308 [TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Tsuchida K; Mathews LS; Vale WW Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11242-6. PubMed ID: 8248234 [TBL] [Abstract][Full Text] [Related]
18. Expression and localization of activin beta A-subunit and activin receptors in TM3, a mouse Leydig cell line. Ying C; Zhang Z; Ying SY Endocr Res; 1995 Nov; 21(4):815-24. PubMed ID: 8582331 [TBL] [Abstract][Full Text] [Related]
19. The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling. Wang T; Danielson PD; Li BY; Shah PC; Kim SD; Donahoe PK Science; 1996 Feb; 271(5252):1120-2. PubMed ID: 8599089 [TBL] [Abstract][Full Text] [Related]
20. Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line. Ying SY; Zhang Z Breast Cancer Res Treat; 1996; 37(2):151-60. PubMed ID: 8750582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]